C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| The invention claimed is: 1. An isolated PC-LECTIN protein comprising the amino acid sequence of SEQ... |
|
Antibodies for use in determining hemoglobin A.sub.1c |
| It is accordingly an object of the present invention to provide a comparatively simple, inexpensive,... |
|
Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives |
| OF THE INVENTION A hapten of the invention is substantially optically pure, and is particularly ... |
|
Immunogens and the use thereof for obtaining antibodies against HBA.sub.1C |
| What is claimed is: 1. Composition of matter consisting essentially of polyclonal antibodies which ... |
|
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| The present invention overcomes the above mentioned drawbacks and provides methods for treating ... |
|
Antibody against a 3-aminophenylboronic-glycated protein complex and its use in an immunoassay |
| OF THE INVENTION The present invention is directed to methods for developing and utilizing ... |
|
Stimulation of chemotaxis by chemotactic peptides |
| Accordingly, it is an object of this invention to provide a synthetic material having chemotactic ... |
|
Biological material pre-fixation treatment |
| OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic ... |
|
Diagnosis of Williams syndrome |
| OF THE INVENTION The present invention is directed to the determination that SVAS and Williams ... |
|
|
Polypeptide that interacts with heat shock proteins
| Details |
Inventors: Patterson, Winston Campbell; Ballinger, Carol A.;
Assignee: Board of Regents, The University of Texas System (Austin, TX)
Primary Examiner: Rawlings; Stephen L.
Assistant Examiner:
Attorney, Agent or Firm: Mueting, Raasch & Gebhardt, P.A.
An isolated polypeptide having negative regulating activity for a heat shock protein is provided. Also provided is an isolated nucleic acid encoding the polypeptide of the invention, methods for identifying inhibitors of the polypeptide and recombinant preparation of the polypeptide. Also provided are compositions such as inhibitor compositions. |
|
DETAILED DESCRIPTION Described herein are the isolation and characterization of a polypeptide, particularly a tetratricopeptide repeat (TPR)-containing polypeptide that is an interactive partner with heat shock proteins. A preferred polypeptide is referred to herein as Carboxyl terminus of Hsc70-Interacting Protein or "CHIP," not only because of its ability to negatively regulate formation of heat shock protein-substrate complexes by interacting with the forward reaction cycle of heat shock proteins and other accessory chaperone cofactors, but also because the polypeptide interacts in an ATP-independent fashion with these heat shock proteins. The nucleic acid and deduced amino acid sequences of this polypeptide in humans, mice, and Drosophila are provided. Accordingly, the present invention provides an isolated polypeptide that negatively regulates binding of a heat shock protein to a substrate. Preferably, the polypeptide negatively regulates the heat shock proteins Hsc70, Hsp70, and Hsp90. The polypeptide can be a recombinant polypeptide. The polypeptide preferably has a molecular weight of about 30 kD to about 40 kD as determined by SDS polyacrylamide gel electrophoresis. The present invention also provides a preferred isolated polypeptide having an amino acid sequence having greater than about 40% sequence identity to that of at least one of SEQ ID NOs. 2, 7, and 8. A particularly preferred polypeptide contains at least amino acids 1 197 from any of the polypeptides of SEQ ID NOs. 2, 7, and 8 is capable of negatively regulating the binding of a heat shock protein to a substrate. The polypeptide can be recombinant. In another preferred embodiment, the present invention further provides an isolated polypeptide having an amino acid sequence represented by at least one of SEQ ID NOs. 2, 7, and 8. Preferably, the polypeptide is capable of negatively regulating the binding of a heat shock protein to a substrate. The polypeptide can be recombinant. In another preferred embodiment, the present invention also provides a polypeptide containing an amino acid sequence represented by at least one of SEQ ID NOs
|
| Related patents |
|
|
1,2-Biguanides
What is claimed is: 1. A substituted biguanide of the formula ##EQU8## wherein R.sub.1 is alkyl of 1-8 carbon atoms, R'.sub.1 is hydrogen or alkyl of 1-8 carbon atoms ...
|
|
|
Biguanide salts
OF THE INVENTION The invention relates to biguanide salts. In another aspect, the invention relates to pharmaceutical preparations which contain the aforementioned ...
|
|
|
Inhibitors of dipeptidyl-aminopeptidase type IV
What is claimed is: 1. A method for treating transplant rejection in a patient comprising administering to said patient an inhibitor of DP-IV, having the structure: ##STR...
|
|
|
Process for preparing anti-obesity protein
OF THE INVENTION For purposes of the present invention, as disclosed and claimed herein, the following terms and abbreviations are as defined below. dDAP--a ...
|
|
|
Use of GLP-1 or analogs to abolish catabolic changes after surgery
The present invention therefore presents for the first time a method of attenuating post-surgical catabolic changes and insulin resistance, comprising, administering to ...
|
|
|
Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury
OF THE INVENTION The present invention provides a method for effective treatment of spinal cord injury. The method involves administering an effective amount of ...
|
|
|
Leptospira rare outer membrane proteins
The present invention presents two novel leptospiral membrane proteins: LipL1 and LipL2. In particular, these proteins are lipoproteins which are associated with ...
|
|
|
Interleukin-1 beta converting enzyme like apoptotic protease-6
Toward these ends, and others, it is an object of the present invention to provide polypeptides, inter alia, that have been identified as novel ICE LAP-6 by homology ...
|
|
|
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
What is claimed is: 1. A therapeutic composition comprising at least one angiogenesis inhibiting agent, which is an .alpha..sub.v.beta..sub.3 antagonist; and at least ...
|
|
|
Expressed sequence tags and encoded human proteins
The present invention relates to purified, isolated, or enriched 5' ESTs which include sequences derived from the authentic 5' ends of their corresponding mRNAs. The ...
|
|
|